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Abstract
1
Mathematical models of angiogenesis, pioneered by P. Hahnfeldt,
are under study. To enrich the dynamics of three models, we intro-
duced biologically motivated time-varying delays. All models under
study belong to a special class of nonlinear nonautonomous systems
with delays. Explicit conditions for the existence of positive global so-
lutions and the equilibria solutions were obtained. Based on a notion
of an M-matrix, new results are presented for the global stability of
the system and were used to prove local stability of one model. For a
local stability of a second model, the recent result for a Lienard-type
second-order differential equation with delays was used. It was shown
that models with delays produce a complex and nontrivial dynamics.
Some open problems are presented for further studies.
. Keywords Angiogenesis, Nonlinear nonautonomous delay differential
equations, Global and local stability, Equilibria, M-matrix, Lienard equa-
tions. MSC 2000: 34K06, 34K20, 34K60.
1 Introduction
Angiogenesis, the generation of new blood vessels, is thought to be necessary
for tumor growth and metastasis [18]–[20]. This process belongs to a general
family of tumor-immune interactions. Some recent studies, including mathe-
matical models of angiogenesis dynamics, are presented in [2], [11], [13], [15]–
[20], [23]–[24], [29], [31] and [32].
To incorporate the spatial effects of the diffusion factors that stimulate and
inhibit angiogenesis, the following two-compartmental model for cancer cells
and vascular endothelial cells was developed by P. Hahnfeldt in [23] (see, also
[31]).
dx
dt
= αx(t) ln
K(t)
x(t)
dK
dt
= −µK(t) + S(x(t), K(t))− I(x(t), K(t))− c(t)K(t),
(1)
where x(t) is the tumor mass and K(t) is a variable carrying capacity, that
is defined as the effective vascular support provided to the tumor as re-
flected by the size of the tumor potentially sustainable by it. According to
P. Hahnfeldt, a stimulator/inhibitor tumor growth dynamics, described by
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system (1), should provide a time dependent carrying capacity under angio-
genic control and include the distinct mechanisms for angiogenic stimulation
and inhibition. The dynamics of the second equation is a balance between
stimulatory and inhibitory effects: first term is the loss of functional vascu-
lature; the second term corresponds the stimulatory capacity of the tumor.
The third term reflects endogenous inhibition by either neutralizing endothe-
lial cell growth factors or inhibition endothelial cell proliferation. These in-
hibitors are released through the tumor surface (scaling the tumor volume
to its surface area); thus the major assumption for the Hahnfeldt models is
I(x,K)/S(x,K) ∼ Kθxµ,
where θ + µ = 2/3.
The last term in model (1) represents inhibition of tumor vasculature due to
administered therapy. The following pharmokinetic differential equation
dc
dt
= v(t)− qc(t)
might be used to model chemo- or radio-therapy mechanisms. Here v(t) is a
dose given and q is a per capita decay rate of the drug once it is injected. If
we assume that the drug kills all types of cells [24], then
dx
dt
= αx(t) ln
K(t)
x(t)
− p(t)x(t)
dK
dt
= −µK(t) + S(x(t), K(t))− I(x(t), K(t))− c(t)K(t).
(2)
To model processes in nature it is frequently required to know system states
from the past, i.e., models incorporating memory. Depending on the phenom-
ena under study the after-effects represent duration of some hidden processes,
for example, time lags of transit through one state to another; transit time
through compartments, or time lags associated with the growth rates (cell
division/differentiation time). In any cell growth some cells are inactive and,
once activated, the cell division is not instantaneous. There are delays in
cell division. For example, cells can be engaged in an active cell cycle and
might divide with a fairly regular periodicity. On the other hand, cells can
be in a resting state (i.e., having dropped out of the cell cycle because of lack
of positive growth signals) and will experience a delay in resuming the cell
cycle at the same place that they left. In human cells this delay is usually
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about 8 hours. One might imagine that in addition to carrying oxygen and
nutrients to tumor cells in a tumor mass, vascularization may also deliver
growth hormones (signals) that would stimulate otherwise quiescent cells to
reenter the cell division cycle and thereby contribute to an increase in tumor
mass. The Warburg effect on angiogenesis and metastasis is a different mech-
anism with the after-effects (see, for example, [27]). Essentially cancer cells
continue to use glycolysis much more than regular cells, even when there
is plenty of oxygen around. This produces an acidic environment (by the
production of lactic acid from glycolysis) which in turn stimulates angiogen-
esis. Presumably there is a lag time required to bring the tumor environment
to the optimal pH for endothelial cell growth. In terms of inhibition, there
could be time lags between cells receiving an inhibitory signal and actually
dropping out of the cell cycle. Usually cells will continue through their cycle
after receiving a signal and all stop at the same spot on the cycle (called a
restriction point). The inclusion of explicit time lags in the model allows di-
rect reference to experimentally measurable and/or controllable cell growth
characteristics (e.g., time required to perform the necessary divisions). In
general, models with delays produce a complex and nontrivial dynamics: it
switches stable trajectories into unstable cycles or periodic oscillations. In
cancer therapy, stability switching is a very important issue in the design of
a drug protocol (see, for example, [1], [3], [14] and [33]).
If we assume that the tumor cells enter the mechanisms of angiogenic
stimulation and inhibition with some delays h(t) ≤ t, then model (1) has two
alternative forms:
Model 1.
dx
dt
= αx(t) ln
K(t)
x(t)
− p(t)x(t)
dK
dt
= βx(h(t))− γK(t)− δx2/3(h(t))K(t)− c(t)K(t).
(3)
Model 2.
dx
dt
= αx(t) ln
K(t)
x(t)
− p(t)x(t)
dK
dt
= βK(t)− γK(t)− δx2/3(h(t))K(t)− c(t)K(t).
(4)
Note that a logistic-type model with Richards nonlinearity
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Model 3.
dx
dt
= αx(t)
(
1−
[
x(t)
K(t)
]m)
− p(t)x(t)
dK
dt
= βx(h(t))− γK(t)− δx2/3(h(t))K(t)− c(t)K(t).
(5)
could also be used for modelling tumor growth dynamics [23]. Here m > 0
and m 6= 1 is a constant that drops an unnatural symmetry of the classical
logistic curve (m = 1).
Note that all models without time lags were studied in [13], [15], [23] and [31].
Systems (3)–(5) belong to a wide class of the delay differential equations
dx
dt
= A(t)x(t) + F (t, x(t), x(h(t))), t ≥ t0, (6)
where x ∈ Rn, A ∈ Rn×n and F : R+ × R
n × Rn → Rn is a nonlinear and
continuous vector function.
Stability analysis of the delay differential equation (6) is a well-trodden area,
however, some existing results rely on restrictive conditions, e.g., strict mono-
tonicity and boundedness of the functions and operators involved, continuity
of the parameters [5], [12], [21], [22], [26], [28] and [30]. For example, mod-
els under study possess non-Lipchitz nonlinearity, thus stability analysis for
models (3)–(5) requires new tools and approaches. Moreover, since the mod-
els in the paper are based on nonautonomous equations, the application of
the traditional methods for autonomous equations, such as Laplace trans-
forms or quasipolynomials, is questionable.
The purpose of this paper is two-fold: obtain new results in the qualitative
theory of delay differential equations; apply the results to the analysis of the
models of angiogenesis dynamics. Firstly, for some general class of nonlinear
nonautonomous systems with delays we obtained conditions for the existence
of a global attractor; and based on that result, we proved local stability for
Model l. Compared with Model 1, Model 2 has different qualitative features,
thus for its analysis, we used the theorems recently obtained for a Lienard-
type second-order differential equation with delays [4]. In the Discussion we
pose some open problems.
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2 Global Stability Criteria
We will begin by examining the global stability of a general class of the
following nonlinear nonautonomous systems with delays.
x˙i(t) = −aii(t)xi(t) +
∑
j 6=i
aij(t)xj(t) +
n∑
j=1
fij(t, x(hij(t))), i = 1, . . . , n, (7)
where |fi,j(t, u)| ≤ bij(t)|u|, aij(t) and bij(t) are measurable essentially bounded
functions, fij(t, ·) is a continuous function, fij(·, u) is a measurable locally
essentially bounded function and hij(t) ≤ t are measurable functions. Along
with equations (7) we set the initial condition for each t0 ≥ 0
xi(t) = ϕi(t), t ≤ t0, i = 1, . . . , n, (8)
where ϕi is a continuous function.
A solution X(t) = {x1(t), . . . , xn(t)}
T of problem (7)-(8) is a vector function,
locally absolutely continuous for t ≥ t0, that satisfies almost everywhere
equation (7) on this interval and initial condition (8) for t ≤ t0. A unique
global solution of problem (7)-(8) exists.
Definition. Matrix A is called an M-matrix if aij ≤ 0, i 6= j and one of
the following equivalent conditions holds:
-there exists a nonnegative inverse matrix A−1 ≥ 0.
-the main minors of matrix A are positive numbers.
Let Aij = supt≥t0 |aij(t)| and Bij = supt≥t0 |bij(t)|.
Theorem 2.1 Suppose there exist ai > 0, τ > 0 and t0 ≥ 0 such that
inft≥t0 aii(t) ≥ ai and t − hij(t) ≤ τ . The matrix B = {bij} with entries
bii = ai − Bii and bij = −Aij − Bij for i 6= j is an M-matrix. Then for any
solution X(t) = {x1(t), . . . , xn(t)}
T of equation (7) limt→∞X(t) = 0.
Proof. After substitution xi(t) = e
−λ(t−t0)yi(t), t ≥ t0, where 0 < λ <
mini ai, system (7) has a form
y˙i(t) = −(aii(t)−λ)yi(t)+
∑
j 6=i
aij(t)yj(t)+
n∑
j=1
eλ(t−t0)fij(t, e
−λ(hij(t)−t0)yj(hij(t))).
Hence
yi(t) = e
−
∫ t
t0
[aii(s)−λ]dsxi(t0) +
∫ t
t0
e−
∫ t
s
[aii(ζ)−λ]dζ
[∑
j 6=i
aij(s)yj(s)
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+n∑
j=1
eλ(s−t0)fij(s, e
−λ(hij(s)−t0)yj(hij(s)))
]
ds.
Then
|yi(t)| ≤ e
−
∫ t
t0
[aii(s)−λ]ds|xi(t0)|+
∫ t
t0
e−
∫ t
s
[aii(ζ)−λ]dζ
[∑
j 6=i
|aij(s)||yj(s)|
+
n∑
j=1
|bij(s)|e
λ(s−hij(s))|yj(hij(s))|
]
ds
≤ |xi(t0)|+
∫ t
t0
e−
∫ t
s
[aii(ζ)−λ]dζ(aii(s)− λ)
[∑
j 6=i
|aij(s)|
aii(s)− λ
|yj(s)|
+
n∑
j=1
eλτ |bij(s)|
aii(s)− λ
|y(hij(s))|
]
ds.
Set ybi = maxt0−τ≤t≤b |yi(t)| and Y
b = {yb1, . . . , y
b
n}
T . Hence
ybi ≤ |xi(t0)|+
∑
j 6=i
Aij
ai − λ
ybj +
n∑
j=1
eλτBij
ai − λ
ybj
for t0 ≤ t ≤ b. We define the matrix C(λ) = {cij(λ)} with entries
cii(λ) = 1−
eλτBii
ai − λ
and cij(λ) = −
Aij + e
λτBij
ai − λ
, i 6= j.
Hence C(λ)Y b ≤ |X(t0)| for t0 ≤ t ≤ b. We have limλ→0C(λ) = C(0). Since
matrix B is an M-matrix, then C(0) is also an M-matrix; thus the main
minors of C(0) are positive. If for some values of parameters the elements
of a matrix are continuous functions then the determinant of this matrix is
a continuous function. For some λ > 0 all main minors of C(λ) are positive,
the latter implies that this matrix is an M-matrix. Assume that parameter is
fixed λ = λ0. Thus for Y
b there is an a priory estimate Y b ≤ C−1(λ0)|X(t0)|
where the right-hand side does not depend on b; therefore Y (t) is a bounded
function. Finally, X(t) = e−λ(t−t0)Y (t), then limt→∞X(t) = 0. The theorem
is proven.
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3 Existence of Global Solutions
In what follows, we assume 0 ≤ t−h(t) ≤ τ , x(t) = φ(t) for t < t0 x(t0) = x0
and K(t0) = K0, where p(t) and c(t) are measurable essentially bounded
functions, h(t) is a measurable function and φ is a continuous function.
Definition 3.1 Any solution of problems (3)– (5) is a locally absolutely
continuous function if it satisfies the equation almost everywhere for t > t0
and the initial conditions for t ≤ t0.
Theorem 3.1 Suppose that t − h(t) ≥ τ0 > 0, φ(t) ≥ 0, x(t0) >
0 and K(t0) > 0. Then systems (3)– (5) have unique global solutions
(x(t), K(t)) positive for t ≥ t0.
Proof. Without loss of generality, we prove the theorem for system (3).
The proof for models 2 and 3 is similar. Suppose for simplicity that t0 = 0.
Consider the second equation in system (3) for t ∈ [0, τ0]. This linear equation
has a form
K˙(t) = a(t)K(t) + b(t), K(0) > 0, b(t) ≥ 0.
Hence K(t) > 0 for t ∈ [0, τ0]. Consider the first equation in system (3) for
t ∈ [0, τ0]. This is a nonlinear ordinary differential equation for the function
x(t) with a known positive function K(t). Since x(0) > 0, then there exists
a local solution of this equation. On the interval of the existence of this
solution we have
x(t) = x(t0)e
∫ t
0 (α ln
K(s)
x(s)
−p(s))ds;
hence on this interval the solution is positive. Suppose that the maximum
interval of the existence of the solution of this equation is [0, t0) for t0 < τ0.
Since x(t) > 0 then limt→t0 x(t) = +∞. Therefore there exists 0 < t1 < t0
such that
x(t) > max
0≤t≤τ0
K(t) for t ∈ [t1, t0).
We have ln K(s)
x(s)
< 0, t ∈ [t1, t0). Then
x˙(t) ≤ −p(t)x(t) for t ∈ [t1, t0).
Finally,
0 < x(t) ≤ x(t1)e
∫ t0
t1
|p(s)|ds for t ∈ [t1, t0).
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It contradicts the assumption that limt→t0 x(t) = +∞. Therefore, there ex-
ists a positive solution of this equation for t ∈ [0, τ0]. Similarly, we apply the
same procedure on the intervals [τ0, 2τ0], [2τ0, 3τ0], . . . and obtain the global
positive solution for system (3). The theorem is proven. Following the steps
in this Theorem, it is straightforward to check the existence of the global
solutions of models (4) and (5).
In view of Theorem 3.1 we assume that there exists 0 < τ1 < τ0 such that
τ1 ≤ t− h(t) ≤ τ0, e.g., h(t) = t− τ .
4 Models with Constant Rate of Infusion
Standard chemo- and radio- therapies are typically administered in a con-
stant dose scheduling, i.e., c(t) = c0 and p(t) = p0.
4.1 Stability Analysis for Model 1
dx
dt
= αx(t) ln
K(t)
x(t)
− p0x(t)
dK
dt
= βx(h(t))− γK(t)− δx2/3(h(t))K(t)− c0K(t).
(9)
Then system
αx ln K
x
− p0x = 0
βx− γK − δx2/3K − c0K = 0,
has a unique positive equilibrium point
x∗ =
(
η−γ−c0
δ
) 3
2
K∗ = x∗e
p0
α
(10)
where η = βe−
p0
α , provided that
β > (γ + c0)e
p0
α . (11)
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Let introduce new variables u(t) = ln x
x∗
and v(t) = ln K
K∗
, then system (9)
has the following exponential form with the trivial equilibrium
du
dt
= −αu(t) + αv(t)
dv
dt
= ηeu(h(t))−v(t) − γ − c0 + (η − γ − c0)e
2u(h(t))
3 .
(12)
At (0, 0) a linearization of system (12) has the following form
du
dt
= −αu(t) + αv(t)
dv
dt
=
η + 2γ + 2c0
3
u(h(t))− ηv(t).
Theorem 4.1 Let t− h(t) ≤ τ and condition (11) holds. Then positive
equilibrium (x∗, K∗) of system (9) is locally asymptotically stable.
Proof. To apply Theorem 2.1 we set a matrix
B =
[
α −α
−η+2γ+2c0
3
η
]
.
Clearly,
B−1 =
3
2α(η − γ − c0)
[
η α
η+2γ+2c0
3
α
]
.
Hence B−1 is anM-matrix, provided that inequality (11) holds. By Theorem
2.1 system (12) is exponentially stable; thus system (9) is locally asymptoti-
cally stable.
4.2 Stability Analysis for Model 2
dx
dt
= αx(t) ln
(
K(t)
x(t)
)
− p0x(t)
dK
dt
= (β − γ)K(t)− δx2/3(h(t))K(t)− c0K(t).
(13)
The system
αx ln
(
K
x
)
− p0x = 0
(β − γ)K − δx2/3K − c0K = 0,
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has a unique positive equilibrium point
x∗ = (
β − γ − c0
δ
)
3
2 , K∗ = x∗e
p0
α , (14)
provided that β > γ + c0.
Set u = ln x
x∗
and v = ln K
K∗
, then system (13) has the following form with
the trivial equilibrium
du
dt
= −αu(t) + αv(t)
dv
dt
= (β − γ − c0)(1− e
2u(h(t))
3 ).
(15)
Nonlinear system (15) is equivalent to a second order delay differential equa-
tion
d2u
dt2
+ α
du
dt
+ A(e2u(h(t))/3 − 1) = 0; (16)
or, if h(t) ≡ t , a second order nonlinear ordinary differential equation
d2u
dt2
+ α
du
dt
+ A(e2u(t)/3 − 1) = 0, (17)
where A = α(β − γ − c0). Equations (16)–(17) belong to a well-known class
of a Lienard-type differential equations [6]–[10].
d2u
dt2
+ f(u)
du
dt
+ g(u) = 0, (18)
or
d2u
dt2
+ f(u)
du
dt
+ g(u(h(t))) = 0. (19)
The following result was obtained by T. Burton [10].
Theorem 4.2 Suppose functions f(u) and g(u) are continuous with f(u) >
0 and ug(u) > 0 if u 6= 0. Then the zero solution of equation (18) is globally
asymptotically stable if and only if∫ ±∞
0
[f(x) + |g(x)|]dx = ±∞.
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For equation (17) we have f(u) = α > 0, g(u) = A(e2u(t)/3 − 1), provided
A > 0 and u(t) > 0 for all t ≥ 0; thus based on Theorem 4.2, system (17) is
globally asymptotically stable.
To prove local stability for Model 2 with delays, we will use the following
result recently obtained by L. Berezansky et al. ([4] Corollary 5.2).
To this end, consider the linear equation
d2u
dt2
+ a(t)
du
dt
+ b(t)u(h(t)) = 0. (20)
Lemma 4.1 Suppose a(t) ≥ a0 > 0, t− h(t) ≤ τ , and
lim sup
t→∞
|b(t)|
a(t)
< τ.
Then equation (20) is exponentially stable.
Theorem 4.3 Suppose
t− h(t) ≤ τ and 0 < β − γ − c0 < 1.5τ. (21)
Then the positive equilibrium of system (13) is locally exponentially stable.
Proof. Stability of the positive equilibrium of system (13) is equivalent to
stability of the trivial solution of equation (16). Linearized equation for (16)
has the form (20), where a(t) = α and b(t) = 2
3
α(β − γ − c0). Finally,
application of Lemma 4.1 proves the theorem.
Remark 4.1 The conditions obtained in Theorem 4.1 are independent
of delays, whereas local stability of Model 2 (Theorem 4.3) depends on the
combination of the magnitude of the delays and some parameters of the model.
5 Models with Time-Varying Treatment
Consider general models (3) and (4), and assume the existence of the limits
lim
t→∞
p(t) = p0 and lim
t→∞
c(t) = c0. (22)
We quote the following lemma [25].
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Lemma 5.1 Consider the vector equation
X˙(t) =
m∑
k=1
Ak(t)X(hk(t)) + F (t), (23)
where Ak(t) and F (t) are locally essentially bounded matrix and vector func-
tions, t− hk(t) ≤ τ . If homogeneous equation
X˙(t) =
m∑
k=1
Ak(t)X(hk(t))
is exponentially stable, and limt→∞ ‖F (t)‖ = 0, then for any solution X of
equation (23)
lim
t→∞
X(t) = 0.
Lemma 5.1 is a simple corollary of the variation of constant formula for solu-
tions of linear delay differential equations and an exponential estimation for
the fundamental matrix of this equation.
Firstly, consider system (3) in the form
dx
dt
= αx(t) ln
(
K(t)
x(t)
)
− p0x(t) + (p0 − p(t))x(t)
dK
dt
= βx(h(t))− γK(t)− δx2/3(h(t))K(t)− c0K(t) + (c0 − c(t))K(t).
(24)
After substitution u = ln x
x∗
and v = ln K
K∗
, system (24) has a form
du
dt
= −αu(t) + αv(t) + p0 − p(t)
dv
dt
= ηeu(h(t))−v(t) − γ − c0 − (η − γ − c0)e
2u(h(t))
3 + c0 − c(t),
(25)
where x∗ and K∗ are defined by (10). Linearization for system (25) yields
du
dt
= −αu(t) + αv(t) + p0 − p(t)
dv
dt
=
η + 2γ + 2c0
3
u(h(t))− ηv(t) + c0 − c(t).
(26)
Lemma 5.1 implies the following result.
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Theorem 5.1 Suppose conditions of Theorem 4.1 and condition (22)
hold. Then the pair of numbers (x∗, K∗), defined by (10), is a local attractor
for the solutions of system (3):
lim
t→∞
x(t) = x∗, lim
t→∞
K(t) = K∗.
Similar calculations yield
Theorem 5.2 Suppose conditions (21) and (22) hold. Then the pair of
numbers (x∗, K∗), defined by (14), is a local attractor for the solutions of
system (4).
Remark 5.1 Note that the methods applicable for Model 1 yield similar
results for the logistic-type model (5).
6 Discussion and Open Problems
Mathematical modeling and simulation can potentially provide insight into
the underlying causes of tumor invasion and metastasis, help understand
clinical observations, and be of use in designing targeted experiments and
assessing treatment strategies [1], [2] and [16]. Compare to some models
in literature, where delays were introduced without biological motivation, we
give a solid justification for the introduction of the delays into the models. All
models are perturbed either by a constant therapy or by time-varying treat-
ments. The existence of unique global solutions for models (3)–(5) follows
from Theorem 3.1. For some general class of nonlinear nonautonomous sys-
tems with delays we obtained conditions for the existence of a global attractor
(Theorem 2.1). Based on Theorem 2.1, we proved local stability for Model l.
For local stability analysis of Model 2 we used recent result for a Lienard-type
second-order differential equation with delays. Criteria obtained for local at-
tractivity, are explicit and hence are convenient to apply/verify in practice.
Note that in Theorems 5.1– 5.2 the study of nonautonomous equations is
reduced to the study of ”limit equations” or asymptotically autonomous sys-
tems. Note that the analysis of Model 3 could be achieved by using similar
techniques.
Finally, we formulate some open problems.
1. Conjecture Model 1 has a global attractor, provided that a positive
equilibrium exists.
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2. Conjecture Model 2 has a global attractor, provided that conditions
of the Theorem 4.2 are satisfied.
3. Some additional problems which were not included in the paper: lower
and upper estimations of the solutions, extinction, existence and asymp-
totic stability of periodic solutions, oscillation and nonoscillation of the
solutions about its positive equilibria.
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